Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

US Patent 11318129 · Granted May 3, 2022

Estimated economic value: $3,420,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Glycyrrhetinic acid derivatives for use in treating hyperkalemia2024
Compounds and methods for inhibiting phosphate transport2023
Compounds and methods for inhibiting phosphate transport2023